tozadenant



tozadenant

O N O S N H O N O H N

SMILES COc1ccc(N2CCOCC2)c2sc(NC(=O)N3CCC(C)(O)CC3)nc12
InChIKey XNBRWUQWSKXMPW-UHFFFAOYSA-N

Chemical Properties

Hydrogen bond acceptors 7
Hydrogen bond donors 2
Rotatable bonds 3
Molecular weight (Da) 406.2


No bioactivity data available.

tozadenant

O N O S N H O N O H N

Drug properties

Molecular type Small molecule
Physiological/Surrogate Surrogate
Approved drug Yes

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV


Compound is not listed as a drug.